These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9707314)

  • 1. Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.
    López-Hernández S; Alarcón T; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):282-5. PubMed ID: 9707314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii.
    Bou G; Cerveró G; Domínguez MA; Quereda C; Martínez-Beltrán J
    Clin Microbiol Infect; 2000 Dec; 6(12):635-43. PubMed ID: 11284921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
    Bou G; Cerveró G; Domínguez MA; Quereda C; Martínez-Beltrán J
    J Clin Microbiol; 2000 Sep; 38(9):3299-305. PubMed ID: 10970374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The high level resistance to carbapenems in Acinetobacter baumannii is a multifactorial problem].
    Bou G
    Enferm Infecc Microbiol Clin; 2001; 19(7):336-8. PubMed ID: 11747791
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
    Alcántar-Curiel MD; García-Torres LF; González-Chávez MI; Morfín-Otero R; Gayosso-Vázquez C; Jarillo-Quijada MD; Fernández-Vázquez JL; Giono-Cerezo S; Rodríguez-Noriega E; Santos-Preciado JI
    Arch Med Res; 2014 Oct; 45(7):553-60. PubMed ID: 25450581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
    Douraghi M; Ghalavand Z; Nateghi Rostami M; Zeraati H; Aliramezani A; Rahbar M; Mohammadzadeh M; Ghourchian S; Boroumand MA; Abdollahi A
    J Appl Microbiol; 2016 Aug; 121(2):401-7. PubMed ID: 27171885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    Marti S; Sánchez-Céspedes J; Alba V; Vila J
    Int J Antimicrob Agents; 2009 Feb; 33(2):181-2. PubMed ID: 18977642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem resistance in Acinetobacter baumannii: where is it heading?
    Deveci Ö; Dal T; Tekin R; Bozkurt F; Tekin A; Dayan S
    Infez Med; 2013 Sep; 21(3):211-5. PubMed ID: 24008854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of resistance to carbapenems in meropenem- resistant Acinetobacter isolates from clinical samples.
    Sinha M; Srinivasa H
    Indian J Med Microbiol; 2007 Apr; 25(2):121-5. PubMed ID: 17582181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
    Hiraki Y; Yoshida M; Masuda Y; Inoue D; Tsuji Y; Kamimura H; Karube Y; Takaki K; Kawano F
    Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.
    Wu W; He Y; Lu J; Lu Y; Wu J; Liu Y
    PLoS One; 2015; 10(9):e0137174. PubMed ID: 26340666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.
    Esterly JS; Qi C; Malczynski M; Scheetz MH
    Pharmacotherapy; 2010 Apr; 30(4):354-60. PubMed ID: 20334455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of metallo-β-lactamases producing Acinetobacter baumannii using microbiological assay, disc synergy test and PCR.
    Purohit M; Mendiratta DK; Deotale VS; Madhan M; Manoharan A; Narang P
    Indian J Med Microbiol; 2012; 30(4):456-61. PubMed ID: 23183473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina.
    Afzal-Shah M; Villar HE; Livermore DM
    J Antimicrob Chemother; 1999 Jan; 43(1):127-31. PubMed ID: 10381110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of imipenem and meropenem against strains of Acinetobacter baumannii isolated from various Chilean hospitals].
    Bello H; Domínguez M; Sepúlveda M; Cerda F; González G; Mella S; Zemelman R
    Rev Esp Quimioter; 2000 Dec; 13(4):405-7. PubMed ID: 11498708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.